title: THA does not affect sleep or EEG spectral power in Alzheimer's disease.
authors.affiliation: Centre d'étude du sommeil, Hôpital du Sacré-Coeur, Montreal, Canada.
authors.forename: D
authors.initials: D
authors.lastname: Petit
authors.forename: J
authors.initials: J
authors.lastname: Montplaisir
authors.forename: D
authors.initials: D
authors.lastname: Lorrain
authors.forename: S
authors.initials: S
authors.lastname: Gauthier
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002540:Cerebral Cortex / Q000187:drug effects; D003344:Cortical Synchronization / Q000187:drug effects; D004569:Electroencephalography / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D008609:Mental Status Schedule; D008875:Middle Aged; D012894:Sleep Stages / Q000187:drug effects*; D012895:Sleep, REM / Q000187:drug effects; D013619:Tacrine / Q000627:therapeutic use*; D014851:Wakefulness / Q000187:drug effects
chemical_list: D013619:Tacrine